Efficacy of quadrivalent human papillomavirus vaccine (Gardasil) for recurrent respiratoru papillomatosis
Not Applicable
- Conditions
- recurrent respiratory papillomatosis
- Registration Number
- JPRN-UMIN000020352
- Lead Sponsor
- Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with severe renal or liver dysfunction, with a risk for general anesthesia, or whom a doctor considered not eligible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of severity of recurrent respiratory papillomatosis based on Dearkay's severity score 3 months after completion of vaccination
- Secondary Outcome Measures
Name Time Method